Acrivon Therapeutics, Inc. Common Stock (ACRV) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 99.22M | 120.44M | 130.36M | 138.41M | 151.33M | 181.63M | 188.98M | 182.36M | 112.14M | 129.69M | 144.49M | 153.28M |
| Cash & Short-Term Investments | 97.74M | 118.58M | 129.25M | 137.42M | 149.63M | 179.48M | 187.45M | 180.54M | 109.97M | 127.46M | 142.09M | 150.95M |
| Cash Only | 34.06M | 41.5M | 35.41M | 41.9M | 39.15M | 39.82M | 43.41M | 46.01M | 24.61M | 36.02M | 29.86M | 38.07M |
| Short-Term Investments | 63.67M | 77.08M | 93.85M | 95.53M | 110.48M | 139.66M | 144.04M | 134.53M | 85.37M | 91.44M | 112.23M | 112.88M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.48M | 1.86M | 1.11M | 989K | 1.69M | 2.15M | 1.53M | 1.82M | 2.17M | 2.23M | 2.4M | 2.33M |
| Total Non-Current Assets | 8.61M | 9.27M | 14.94M | 20.17M | 25.02M | 14.96M | 25.7M | 48.23M | 8.38M | 8.57M | 6.6M | 6.77M |
| Property, Plant & Equipment | 6.91M | 7.42M | 7.98M | 8.12M | 7.98M | 8.03M | 8.47M | 7.44M | 7.61M | 7.91M | 6.19M | 6.36M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 5.11M | 10.2M | 15.2M | 5.09M | 15.39M | 39.9M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.7M | 1.86M | 1.85M | 1.85M | 1.84M | 1.84M | 1.84M | 889K | 765K | 665K | 411K | 408K |
| Total Assets | 107.83M | 129.72M | 145.3M | 158.58M | 176.35M | 196.59M | 214.68M | 230.59M | 120.52M | 138.26M | 151.09M | 160.05M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -38.85% | -34.02% | -32.32% | -31.23% | 46.32% | 42.18% | 42.09% | 44.07% | -29.19% | -23.71% | 72.26% | 68.48% |
| Total Current Liabilities | 11.05M | 15.66M | 14.89M | 13.43M | 13.55M | 17.21M | 14.82M | 11.28M | 9.04M | 13.3M | 9.3M | 7.02M |
| Accounts Payable | 1.16M | 2.28M | 996K | 1.16M | 3.69M | 758K | 1.51M | 1.26M | 2.06M | 5.05M | 1.5M | 1.27M |
| Days Payables Outstanding | 404.06 | -165.27 | - | 736.19 | 643.75 | 343.71 | - | - | 1.44K | 2.02K | - | - |
| Short-Term Debt | 1.15M | 0 | 1.18M | 1.15M | 0 | 1.06M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.74M | 5.56M | 12.71M | 11.12M | 2.13M | 5.46M | 4.03M | 2.95M | 1.91M | 3.86M | 3.01M | 2.06M |
| Current Ratio | 8.98x | 7.69x | 8.75x | 10.31x | 11.17x | 10.55x | 12.75x | 16.16x | 12.40x | 9.75x | 15.54x | 21.84x |
| Quick Ratio | 8.98x | 7.69x | 8.75x | 10.31x | 11.17x | 10.55x | 12.75x | 16.16x | 12.40x | 9.75x | 15.54x | 21.84x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.26M | 1.54M | 1.8M | 2.12M | 2.41M | 2.59M | 2.97M | 3.24M | 3.5M | 3.77M | 3.64M | 3.85M |
| Long-Term Debt | 1.26M | 0 | 1.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 1.54M | 0 | 2.12M | 2.41M | 2.59M | 2.97M | 3.24M | 3.5M | 3.77M | 3.64M | 3.85M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 12.32M | 17.2M | 16.7M | 15.55M | 15.96M | 19.8M | 17.79M | 14.53M | 12.54M | 17.07M | 12.94M | 10.87M |
| Total Debt | 2.42M | 2.71M | 2.99M | 3.26M | 3.51M | 3.65M | 4.01M | 4.22M | 4.45M | 4.64M | 4.42M | 4.6M |
| Net Debt | -31.65M | -38.79M | -32.42M | -38.63M | -35.64M | -36.17M | -39.4M | -41.78M | -20.16M | -31.37M | -25.44M | -33.47M |
| Debt / Equity | 0.03x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.04x | 0.04x | 0.03x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | -11.76x | - | - |
| Total Equity | 95.52M | 112.52M | 128.6M | 143.04M | 160.39M | 176.79M | 196.89M | 216.06M | 107.98M | 121.19M | 138.15M | 149.18M |
| Equity Growth % | -40.45% | -36.35% | -34.68% | -33.8% | 48.54% | 45.87% | 42.52% | 44.83% | -32.71% | -28.91% | 402.85% | 507.87% |
| Book Value per Share | 2.47 | 2.92 | 3.34 | 3.72 | 4.18 | 4.62 | 5.17 | 5.98 | 4.78 | 5.43 | 6.26 | 6.79 |
| Total Shareholders' Equity | 95.52M | 112.52M | 128.6M | 143.04M | 160.39M | 176.79M | 196.89M | 216.06M | 107.98M | 121.19M | 138.15M | 149.18M |
| Common Stock | 38K | 31K | 31K | 31K | 31K | 31K | 31K | 31K | 23K | 23K | 22K | 22K |
| Retained Earnings | -293.92M | -274.88M | -255.9M | -237.66M | -216.66M | -196.98M | -174.15M | -151.7M | -132.91M | -116.42M | -97.17M | -82.7M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 4K | 111K | 112K | 106K | 283K | 447K | 782K | -19K | -70K | -83K | -302K | -427K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |